Clinical Subject Page
Rheumatic Heart Disesae
Also called
Chronic, heart-related Conditions
ICD-10
I09.9
Specialty
Cardiology
Onset
Chronic
Reviewed
June 2026
On This Page
-
OverviewOverview
-
Etiology & Risk FactorsEtiology & Risk Factors
-
PathophysiologyPathophysiology
-
Clinical PresentationClinical Presentation
-
History TakingHistory Taking
-
Physical ExaminationPhysical Examination
-
InvestigationsInvestigations
-
DiagnosisDiagnosis
-
ManagementManagement
-
ComplicationsComplications
-
PrognosisPrognosis
-
Key Points / Clinical PearlsKey Points / Clinical Pearls
Overview
Rheumatic heart disease (RHD) is a chronic heart condition caused by permanent damage to the heart valves following acute rheumatic fever, which occurs after an untreated group A β-hemolytic streptococcal (strep throat) infection.
Teaching point
The mitral valve is most commonly affected, although the aortic valve may also be involved. Over time, valve damage can lead to stenosis (narrowing), regurgitation (leakage), or both, resulting in heart failure and other complications if untreated.
Etiology & Risk Factors
- Untreated or inadequately treated group A β-hemolytic Streptococcus (Streptococcus pyogenes) infection
- Most commonly strep throat (acute tonsillitis/pharyngitis)
- Less commonly after group A streptococcal skin infections
- Acute rheumatic fever usually develops 2–4 weeks after the infection.
- The resulting inflammation can permanently damage the heart valves, especially the mitral valve, leading to rheumatic heart disease.
Risk Factors
- Untreated or recurrent group A streptococcal throat infections
- Previous episode of acute rheumatic fever
- Age 5–15 years (highest risk for acute rheumatic fever)
- Living in resource-limited or overcrowded settings, where streptococcal infections are more common
- Limited access to prompt antibiotic treatment for streptococcal infections
Pathophysiology
- Untreated group A β-hemolytic streptococcal (GAS) throat infection occurs.
- The body produces antibodies against the streptococcal M protein.
- Due to molecular mimicry, these antibodies cross-react with cardiac proteins (especially myosin).
- This causes a type II hypersensitivity reaction, leading to acute rheumatic fever (ARF) and inflammation of the heart (carditis/valvulitis).
- Recurrent or severe inflammation causes permanent scarring and fibrosis of the heart valves, resulting in rheumatic heart disease (RHD).
- The mitral valve is most commonly affected, followed by the aortic valve, leading to valve stenosis, regurgitation, or both.
Simple Flow
Untreated strep throat → Antibodies against streptococcal M protein → Molecular mimicry → Autoimmune attack on heart valves → Carditis/valvulitis → Valve scarring and fibrosis → Chronic rheumatic heart disease
Clinical Presentation
General Symptoms
- Fever
- Malaise
- Fatigue
Cardiac Manifestations
- Carditis (pancarditis) – inflammation of the endocardium, myocardium, and pericardium
- Heart murmur due to valve disease
- Symptoms of heart failure in severe disease
Joint Manifestations
- Migratory polyarthritis (pain and swelling that moves from one large joint to another)
Neurologic Manifestations
- Sydenham chorea (involuntary, irregular movements)
Skin Manifestations
- Subcutaneous nodules
- Erythema marginatum (nonpruritic rash with central clearing)
Valve Involvement
- Mitral valve (most common)
- Early: Mitral regurgitation
- Late: Mitral stenosis
- Aortic valve
- Aortic regurgitation
- Late aortic stenosis
High-Yield Mnemonic: JONES
- J – Joints (migratory polyarthritis)
- O – (Carditis/Pancarditis)
- N – Nodules (subcutaneous)
- E – Erythema marginatum
- S – Sydenham chorea
Important Note
Mitral valve is the most commonly affected valve; the aortic valve is the second most commonly affected.
History Taking
Diagnosis rests on the combination of clinical history, ECG findings, and cardiac biomarkers.
- “Have you had a sore throat or strep throat in the past few weeks?”
- “Was it treated with antibiotics?”
- “Have you had a fever recently?”
- “Do you have pain or swelling that moves from one joint to another?”
- “Do you get short of breath during activity or when lying flat?”
- “Do you have chest pain or palpitations?”
- “Do you feel unusually tired or weak?”
- “Have you noticed any skin rash or painless lumps under your skin?”
- “Have you had any unusual jerky or involuntary movements?”
- “Have you ever been told you have a heart murmur, rheumatic fever, or a heart valve problem?”
- “Have you had rheumatic fever or repeated throat infections in the past?”
Physical Examination
General
- Fever
- Appears tired or unwell (malaise)
Cardiovascular
- Heart murmur due to valvular disease
- Signs of carditis (pancarditis)
- Signs of heart failure in severe cases
Joints
- Migratory arthritis involving the large joints (e.g., knees, ankles, elbows, wrists)
- Swollen and tender joints
Skin
- Erythema marginatum (nonpruritic rash with central clearing)
- Subcutaneous nodules over extensor surfaces
Neurological
- Sydenham chorea (involuntary, irregular movements)
Cardiac Examination Findings
- Murmur of mitral regurgitation (acute rheumatic valvulitis)
- Murmur of aortic regurgitation
- In chronic RHD, findings of mitral stenosis may be present
Investigations
Laboratory Tests
- Complete blood count (CBC) – may show leukocytosis or anemia
- ESR and CRP – elevated inflammatory markers
- Antistreptolysin O (ASO) titer – elevated
- Anti-DNase B titer – elevated
- Throat swab/culture or rapid streptococcal antigen test to identify recent GAS infection
Cardiac Investigations
- Echocardiography (Gold standard) – detects valvular damage (e.g., mitral regurgitation, aortic regurgitation, or chronic mitral stenosis)
- ECG – commonly shows prolonged PR interval (first-degree AV block); may also show other conduction abnormalities
- Chest X-ray – may show enlarged left atrium, enlarged left ventricle, or pulmonary edema
Diagnosis
Acute Rheumatic Fever · Jones Criteria (2015 AHA Revision)
ARF Diagnosis requires evidence of preceding Group A Streptococcal (GAS) infection
PLUS: 2 Major criteria — OR — 1 Major + 2 Minor criteria. Criteria thresholds differ by population risk.
Diagnostic formula
Evidence of GAS infection
+
2 Major
OR
1 Major + 2 Minor
=
ARF Diagnosis
Major Criteria 5 features
1. Carditis
Clinical Pancarditis: endocarditis (new valvular regurgitation — mitral > aortic), myocarditis, pericarditis
Subclinical Echocardiographic mitral or aortic regurgitation meeting Doppler criteria without auscultatory findings — counts as major in high-risk populations
Subclinical Echocardiographic mitral or aortic regurgitation meeting Doppler criteria without auscultatory findings — counts as major in high-risk populations
2. Polyarthritis
Low-risk Migratory polyarthritis (≥2 large joints)
High-risk Monoarthritis or polyarthralgia may count as major (see population note)
Joints: knees, ankles, wrists, elbows — migratory, swollen, hot, painful. Responds dramatically to aspirin.
High-risk Monoarthritis or polyarthralgia may count as major (see population note)
Joints: knees, ankles, wrists, elbows — migratory, swollen, hot, painful. Responds dramatically to aspirin.
3. Chorea (Sydenham's)
Involuntary, purposeless, rapid movements; emotional lability; muscular weakness. May appear weeks–months after GAS infection. Sufficient alone for ARF diagnosis (monosymptomatic chorea).
4. Erythema Marginatum
Evanescent, non-pruritic, pink/red rash with central clearing and serpiginous margins. Trunk and proximal limbs; spares face. Rare (<5% of cases).
5. Subcutaneous Nodules
Firm, painless nodules over bony prominences and tendons (elbows, wrists, knees, spinous processes, occiput). 0.5–2 cm. Associated with severe carditis. Very rare.
Minor Criteria 5 features
1. Fever
Low-risk ≥38.5°C
High-risk ≥38.0°C
Documented at time of presentation
High-risk ≥38.0°C
Documented at time of presentation
2. Elevated ESR / CRP
Low-risk ESR ≥60 mm/h and/or CRP ≥3.0 mg/dL
High-risk ESR ≥30 mm/h and/or CRP ≥3.0 mg/dL
High-risk ESR ≥30 mm/h and/or CRP ≥3.0 mg/dL
3. Prolonged PR interval
Age-adjusted first-degree AV block on ECG. Cannot be used as minor criterion if carditis is already counted as a major criterion.
4. Monoarthralgia
High-risk populations only Joint pain without objective signs of inflammation — only qualifies as minor in high-risk populations after excluding other causes.
5. Monoarthritis
High-risk populations only Inflammation in a single joint — may be downgraded from major to minor in low-risk settings, or used as minor in high-risk populations if monoarthralgia is already counted.
Mandatory: Evidence of preceding GAS infection
Serological
Elevated or rising ASO titre
Elevated or rising anti-DNase B titre
Other streptococcal antibodies (anti-streptokinase, anti-hyaluronidase)
Microbiological
Positive throat culture for GAS
Positive rapid antigen test for GAS
Note: positive swab may reflect chronic carriage; serology preferred
Special exceptions
Chorea alone: GAS evidence not always required (long latency)
Insidious-onset carditis alone: GAS evidence may be absent
Recurrent ARF: requires only 1 major OR 2 minor + GAS evidence
Low-risk populations
ARF incidence <2 per 100,000 school-age children per year, OR RHD prevalence <1 per 1,000 per year
- Stricter thresholds apply (higher fever cutoff, higher ESR)
- Monoarthritis/monoarthralgia do not count as major criteria
- Subclinical carditis on echo counts as major only in high-risk
High-risk populations
ARF incidence ≥2 per 100,000 school-age children, OR RHD prevalence ≥1 per 1,000 per year
- Lower fever and ESR thresholds apply
- Monoarthritis counts as major; monoarthralgia counts as minor
- Subclinical carditis on echo counts as major criterion
Management
1. Eradicate Streptococcal Infection
- Treat the group A streptococcal (GAS) infection with antibiotics.
2. Long-Term Antibiotic Prophylaxis
- Essential for all patients with ARF or RHD to prevent recurrence.
- First-line: Intramuscular benzathine penicillin G every 4 weeks.
- Alternatives:
- Oral penicillin V
- Sulfadiazine or a macrolide for patients with a confirmed penicillin allergy
3. Manage Cardiac Complications
- Refer patients with carditis or RHD to cardiology.
- Treat heart failure according to guideline recommendations.
- Anticoagulation if atrial fibrillation develops.
- Consider endocarditis prophylaxis in high-risk patients and treat endocarditis promptly if it occurs.
4. Valve Disease Management
- Valvuloplasty or heart valve replacement may be required for severe valvular disease.
5. Follow-Up
- Regular echocardiography for long-term monitoring.
- Educate patients about:
- Adhering to antibiotic prophylaxis
- Seeking prompt treatment for sore throats
- Maintaining good dental hygiene
Complications
- Permanent valvular heart disease (especially mitral valve, followed by the aortic valve)
- Heart failure
- Atrial fibrillation
- Infective endocarditis
- Progressive worsening of valve disease, which may require valvuloplasty or heart valve replacement
- Recurrent acute rheumatic fever, leading to further valve damage if long-term antibiotic prophylaxis is not maintained
Prognosis
- Cardiac involvement is the most important prognostic factor.
- Patients with carditis are at high risk of developing permanent valvular heart disease (rheumatic heart disease), especially with recurrent episodes of acute rheumatic fever.
- Early death from acute rheumatic fever is usually due to myocarditis, rather than valvular disease.
- Long-term antibiotic prophylaxis helps prevent recurrent acute rheumatic fever and slows progression of rheumatic heart disease.
Key Points / Clinical Pearls
- RHD is a chronic complication of acute rheumatic fever.
- Caused by untreated group A streptococcal (strep throat) infection.
- Mitral valve is most commonly affected; aortic valve is second.
- Jones criteria are used to diagnose acute rheumatic fever.
- Gold standard for assessing valve damage: Echocardiography.
- Main treatment: Eradicate streptococcal infection, long-term penicillin prophylaxis, manage complications, and perform valve repair/replacement if severe.
- Preventing recurrent acute rheumatic fever is essential to reduce progression of rheumatic heart disease.
- National Center for Biotechnology Information (NIH). Rheumatic Heart Disease, StatPearls.
- World Health Organization. Rheumatic Heart Disease: Fact Sheet.
- World Health Organization. WHO Guideline on the Prevention and Diagnosis of Rheumatic Fever and Rheumatic Heart Disease. Geneva: WHO; 2024.
- Gewitz MH, Baltimore RS, Tani LY, et al; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease. Revision of the Jones Criteria for the Diagnosis of Acute Rheumatic Fever in the Era of Doppler Echocardiography. Circulation. 2015;131:1806-1818. PMID: 25908771.
- MedlinePlus, National Library of Medicine (NIH). Rheumatic Heart Disease: Medical Encyclopedia.